Journal article

Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity

DK Cole, AM Bulek, G Dolton, AJ Schauenberg, B Szomolay, W Rittase, A Trimby, P Jothikumar, A Fuller, A Skowera, J Rossjohn, C Zhu, JJ Miles, M Peakman, L Wooldridge, PJ Rizkallah, AK Sewell

Journal of Clinical Investigation | AMER SOC CLINICAL INVESTIGATION INC | Published : 2016

Open access

Abstract

The cross-reactivity of T cells with pathogen- and self-derived peptides has been implicated as a pathway involved in the development of autoimmunity. However, the mechanisms that allow the clonal T cell antigen receptor (TCR) to functionally engage multiple peptide-major histocompatibility complexes (pMHC) are unclear. Here, we studied multiligand discrimination by a human, preproinsulin reactive, MHC class-I-restricted CD8+ T cell clone (1E6) that can recognize over 1 million different peptides. We generated high-resolution structures of the 1E6 TCR bound to 7 altered peptide ligands, including a pathogenderived peptide that was an order of magnitude more potent than the natural self-pepti..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Research Councils UK


Funding Acknowledgements

Primary support for this work was provided by the UK Biotechnology and Biological Sciences Research Council (grant BB/H001085/1). A.K. Sewell is a Wellcome Trust Investigator. D.K. Cole is a Wellcome Trust Research Career Development Fellow (WT095767). P.J. Rizkallah was supported by a RCUK Fellowship. Support for 2D affinity studies was provided by US NIH (grant R01AI124680-01 and R01GM096187 to C. Zhu). We thank the MX staff on beamlines IO2, IO3, IO4-1, and I24, as well as CD staff on beamline B23 at DLS for providing facilities and support.